October 2020 Price Concessions 1st Update


October 2020 Price Concessions 1st Update

October 15, 2020

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack Size Price Concession
Duloxetine 20mg gastro-resistant capsules 28 £7.99
Duloxetine 60mg gastro-resistant capsules 28 £4.10
Enalapril 10mg tablets 28 £5.49
Enalapril 20mg tablets 28 £10.00
Estradiol 1mg tablets 84 £6.89
Estradiol 2mg tablets 84 £6.89
Hydroxyzine 10mg tablets 84 £1.77
Moxonidine 200microgram tablets 28 £9.46
Moxonidine 300microgram tablets 28 £10.99
Moxonidine 400microgram tablets 28 £12.07
Naftidrofuryl 100mg capsules 84 £7.25
Olanzapine 15mg tablets 28 £3.95
Olanzapine 20mg tablets 28 £5.10
Oxytetracycline 250mg tablets 28 £9.10
Senna 7.5mg tablets 60 £2.76
Sertraline 100mg tablets 28 £6.72
Sertraline 50mg tablets 28 £4.74
Valsartan 160mg capsules 28 £12.01

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated October 2020 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC. No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.


Posted in:

More Latest News >

April CPN magazine published

The April 2021 edition of PSNC’s Community Pharmacy News (CPN) is now available. This issue of CPN features: Negotiations begin...